Licensing Agreements

ABVC BioPharma Receives $566,000 in Cumulative Payments Under Vitargus Licensing Agreement
ABVC BioPharma has received cumulative payments of $566,000 from ForSeeCon Eye Corporation under their Vitargus licensing agreement, with the funds supporting GMP facility preparation for the biodegradable vitreous substitute's production.
October 8, 2025

AXIM Biotechnologies Partners with JK Medical to Expand Ocular Diagnostic Access Across Latin America
AXIM Biotechnologies has entered an exclusive licensing agreement with JK Medical to distribute its TearScan® diagnostic tests across seven Latin American countries, addressing critical unmet needs in dry eye disease diagnosis through rapid point-of-care testing.
October 7, 2025